This medication contains 2 medicines: atovaquone and proguanil. It is used to prevent and treat malaria caused by mosquito bites in countries where malaria is common. Malaria parasites can enter ...

AvKARE pulled only lot No. AW0221A, expiration date 08/2025 of Atovaquone Oral Suspension, USP 750mg/5mL. The NDC number and ...

AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found ...

Babesiosis infections can range from asymptomatic to severe. Many people don’t feel any symptoms, but those who do may have ...

Review the side-effects of Atovaquone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Several medications, including doxycycline, atovaquone/proguanil, mefloquine, and primaquine, have proven effective. But malaria is one of nature's most resilient killers, and the Plasmodium ...

Briefly, the CDC recommends that travelers to malaria-risk areas of South America, Africa, the Indian subcontinent, and the South Pacific take either mefloquine or doxycycline or atovaquone and ...

AvKARE recalled one lot of Atovaquone Oral Suspension after third-party testing discovered a potential Bacillus cereus contamination in the medicine. As for what that means, the risk statement in ...